Literature DB >> 8406813

Role of gamma interferon in late stages of murine salmonellosis.

A Muotiala1, P H Mäkelä.   

Abstract

Gamma interferon (IFN-gamma) is an important mediator of natural resistance of mice to Salmonella species during the first week of infection, when it restricts the rate of intracellular growth of the bacteria but does not lead to their killing (A. Muotiala and P. H. Mäkelä, Microb. Pathog. 8:135-141, 1990). We used the experimental mouse salmonellosis model to investigate the role of IFN-gamma in the later stages of a sublethal infection and the ensuing specific immunity. When anti-IFN-gamma was administered starting 6 days after challenge, it did not prevent the cessation of intracellular bacterial growth and the formation of the plateau stage in the second week of infection. In addition, anti-IFN-gamma given 14 and 16 days after challenge did not alter the elimination of the bacteria in the clearance stage in the third week of infection. When mice immunized 2 months previously with live vaccine were infected with virulent salmonellae, depletion of IFN-gamma enhanced the early growth of the bacteria in the same manner as that seen in naive mice. However, when the immunized mice were infected with attenuated aroA bacteria, their clearance started immediately and was unaffected by IFN-gamma depletion, demonstrating that IFN-gamma is not required for the clearance. We conclude that IFN-gamma restricts the rate of intracellular bacterial multiplication in the first week of Salmonella infection in both naive and immune mice but is not a mediator of bacterial clearance in either naive or immunized mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406813      PMCID: PMC281151          DOI: 10.1128/iai.61.10.4248-4253.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Alternative complement pathway activation by Salmonella O polysaccharide as a virulence determinant in the mouse.

Authors:  H Saxén; I Reima; P H Mäkelä
Journal:  Microb Pathog       Date:  1987-01       Impact factor: 3.738

3.  The initial suppression of bacterial growth in a salmonella infection is mediated by a localized rather than a systemic response.

Authors:  D J Maskell; C E Hormaeche; K A Harrington; H S Joysey; F Y Liew
Journal:  Microb Pathog       Date:  1987-04       Impact factor: 3.738

4.  Evidence for the importance of O antigen specific antibodies in mouse-protective Salmonella outer membrane protein (porin) antisera.

Authors:  H Saxén; M Nurminen; N Kuusi; S B Svenson; P H Mäkelä
Journal:  Microb Pathog       Date:  1986-10       Impact factor: 3.738

5.  The traT protein is able to normalize the phenotype of a plasmid-carried permeability mutation of Salmonella typhimurium.

Authors:  S Sukupolvi; D O'Connor; M F Edwards
Journal:  J Gen Microbiol       Date:  1986-08

Review 6.  Auxotrophic Salmonella typhi as live vaccine.

Authors:  B A Stocker
Journal:  Vaccine       Date:  1988-04       Impact factor: 3.641

7.  Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity.

Authors:  K Kagaya; K Watanabe; Y Fukazawa
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

8.  Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice.

Authors:  G J Bancroft; K C Sheehan; R D Schreiber; E R Unanue
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

9.  Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine.

Authors:  L M Killar; T K Eisenstein
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

10.  Macrophage-mediated mitogenic suppression induced in mice of the C3H lineage by a vaccine strain of Salmonella typhimurium.

Authors:  J C Lee; C W Gibson; T K Eisenstein
Journal:  Cell Immunol       Date:  1985-03       Impact factor: 4.868

View more
  16 in total

1.  Gamma interferon enhances internalization and early nonoxidative killing of Salmonella enterica serovar Typhimurium by human macrophages and modifies cytokine responses.

Authors:  Melita A Gordon; Dominic L Jack; David H Dockrell; Margaret E Lee; Robert C Read
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  IFNγ expression by an attenuated strain of Salmonella enterica serovar Typhimurium improves vaccine efficacy in susceptible TLR4-defective C3H/HeJ mice.

Authors:  Samia M Al-Ojali; C B Tara Moore; Maria J Fernandez-Cabezudo; Basel K Al-Ramadi
Journal:  Med Microbiol Immunol       Date:  2012-06-10       Impact factor: 3.402

3.  Th1 response in Salmonella typhimurium-infected mice with a high or low rate of bacterial clearance.

Authors:  S Pie; P Truffa-Bachi; M Pla; C Nauciel
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

4.  Interleukin-12 is critical for induction of nitric oxide-mediated immunosuppression following vaccination of mice with attenuated Salmonella typhimurium.

Authors:  M G Schwacha; T K Eisenstein
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

5.  Gamma interferon-independent effects of interleukin-12 on immunity to Salmonella enterica serovar Typhimurium.

Authors:  Jason D Price; Kim R Simpfendorfer; Radhakrishnam R Mantena; James Holden; William R Heath; Nico van Rooijen; Richard A Strugnell; Odilia L C Wijburg
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

6.  The capsular polysaccharide complex of Bacteroides fragilis induces cytokine production from human and murine phagocytic cells.

Authors:  F C Gibson; A O Tzianabos; A B Onderdonk
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

7.  Early interferon-γ production in human lymphocyte subsets in response to nontyphoidal Salmonella demonstrates inherent capacity in innate cells.

Authors:  Tonney S Nyirenda; Anna E Seeley; Wilson L Mandala; Mark T Drayson; Calman A MacLennan
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

8.  Induction of antimicrobial pathways during early-phase immune response to Salmonella spp. in murine macrophages: gamma interferon (IFN-gamma) and upregulation of IFN-gamma receptor alpha expression are required for NADPH phagocytic oxidase gp91-stimulated oxidative burst and control of virulent Salmonella spp.

Authors:  N Foster; S D Hulme; P A Barrow
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Virulent Salmonella enterica infections can be exacerbated by concomitant infection of the host with a live attenuated S. enterica vaccine via Toll-like receptor 4-dependent interleukin-10 production with the involvement of both TRIF and MyD88.

Authors:  Gemma L Foster; Tom A Barr; Andrew J Grant; Trevelyan J McKinley; Clare E Bryant; Andrew MacDonald; David Gray; Masahiro Yamamoto; Shizuo Akira; Duncan J Maskell; Pietro Mastroeni
Journal:  Immunology       Date:  2008-02-01       Impact factor: 7.397

10.  Bacterial growth rate and host factors as determinants of intracellular bacterial distributions in systemic Salmonella enterica infections.

Authors:  Andrew J Grant; Gemma L Foster; Trevelyan J McKinley; Sam P Brown; Simon Clare; Duncan J Maskell; Pietro Mastroeni
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.